lung cancer | |||||
新闻 | |||||
ESMO: GSK, iTeos bring some optimism back to TIGIT - Pharmaphorum GSK and iTeos anti-TIGIT antibody belrestotug showed efficacy in a phase 2 trial in PD-L1-positive non-small cell lung cancer (NSCLC), ...
| |||||
DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors CLDN6 is expressed in several tumor types including endometrial, ovarian and gastric cancers ... Lung Cancer. Contacts. Global/US Media: Jennifer ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment